Total Thyroidectomy for Nodular, Benign Thyroid Diseases in Terms of Larynx Function Examinations - Is it a New Treatment Standard?

• Authors: Krzysztof Kaczka , Wojciech Jankowski , Jerzy Kopczyński , Joanna Kwiecień , Lech Pomorski
• Languages of publication: EN

Abstracts

EN

Aim of the study was the assessment of total thyroidectomy (TT) value as a treatment method of goiter with particular emphasis on the results of laryngological examination.Material and methods. From 15th April 2008 to 1st July 2009 there were 125 (72.7%) TTs, 12 (7%) TTs and appropriate lymphadenectomies, 9 (5.2%) near TTs, 14 (8.1%) lobectomies, 5 (2.9%) completion thyroidectomies and 6 (3.4%) other operations. Vocal cords function was assessed routinely one day before, two days after operation by an otolaryngologist. Voice quality was assessed by patients in VHI questionnaire theirselves.Results. Five patients had one-sided vocal cord paralysis before the operation. The one-sided transient recurrent laryngeal nerve injuries was observed in 16 other patients (9.3% among patients and 4.6% among nerves at risk) in the second day after the operation. There was no bilateral recurrent laryngeal nerve injury. From three to six months after the operation, 21 (among 23) patients with vocal cord movement disability were examined once again by the same otolaryngologist. The same vocal cord paralysis was observed in 4 sicks (one person died), which was found preoperatively. Seven (4%) other patients had permanent one vocal cord paresis. This represents 2% the nerves at risk. Three of them were recognized benign lesions and four thyroid cancer. Our percentage of early, postoperative hypoparathyroidism was 6.4% and persistent was 1.7%. VHI score in the group with paresis or paralysis of vocal cord gave the score of 4 to 90 points- an average of 49 points. In patients with proper vocal cord movement there were results from 0 to 6 points- an average of 2 points.Conclusions. 1. Total thyroidectomy in the treatment of bilateral goiter without malignancy features is radical and safe procedure. 2. It protects against goiter relapse and its consequences. 3. Complications rates after total thyroidectomy are at acceptable and comparable proportions to the other operation types.

Keywords

EN

nodular goiter; total thyroidectomy; subtotal thyroidectomy; recurrent laryngeal nerve; hipoparathyroidism

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2010
• Volume: 82
• Issue: 1
• Pages: 4-11

Dates

published

1 - 1 - 2010

online

10 - 2 - 2010

Contributors

author

Krzysztof Kaczka

• Department of General and Oncological Surgery, Medical University, Łódź

author

Wojciech Jankowski

• Department of General and Oncological Surgery, Medical University, Łódź

author

Jerzy Kopczyński

• Department of Otolaryngology, Maria Skłodowska-Curie Memorial Hospital, Zgierz

author

Joanna Kwiecień

• Department of Otolaryngology, Maria Skłodowska-Curie Memorial Hospital, Zgierz

author

Lech Pomorski

• Department of General and Oncological Surgery, Medical University, Łódź

References

• Cady B: Our AMES is true: how an old concept still hits the mark; or, risk group assignment points te arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1998; 174: 462-68.
• Clark OH: Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982; 196: 361-70.
• Reeve TS, Delbridge L, Cohen A et al.: Total Thyroidectomy. Ann Surg 1987; 206: 782-86.
• Kurihara H, Takahashi M: Safety of operation and indications for total thyroidectomy. Operation 1981; 35: 1077-86.
• Delbridge L, Guinea AI, Reeve TS: Total Thyroidectomy for bilateral benign multinodular goiter. Arch Surg 1999; 134: 1389-93.
• Agarwal G, Agarwal V: Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review. World J Surg 2008; 32: 1313-24.[WoS][PubMed][Crossref]
• Bron LP, O'Brien CJ: Total thyroidectomy for clinically benign disease of the thyroid gland. Br J Surg 2004; 91: 569-74.[Crossref][PubMed]
• Pattou F, Combemale F, Fabre S et al.: Hypocalcaemia following thyroid surgery incidence and prediction of outcome. World J Surg 1998; 22: 718-24.[Crossref]
• Gough IR: Total thyroidectomy: indications, technique and training. ANZ J Surg 1992; 62: 87-9.
• Bellantone R, Lombardi CP, Bossola M et al.: Total thyroidectomy for managment of benign thyroid disease: review of 526 cases. World J Surg 2002; 26: 1468-71.
• Rudzki S., Matuszek M, Matras P: Analiza przyczyn wczesnych powikłań po strumektomii. Wiad Lek 2006; 59: 149-55.
• Jurecka-Lubieniecka B, Paliczka E, Czarniecka A: Niedoczynność przytarczyc po operacji raka tarczycy: czy istnieje szansa na opóźnione samoistne wyrównanie funckji gruczołów. Endokrynol Pol 2006; 57: 501-08.
• Efremidou EI, Papageorgiou MS, Liratzopoulos N: The efficacy and safety of Total thyroidectomy in the management of benin thyroid disease: a review of 932 cases. Can J Surg 2009; 52: 39-44.
• Weber KJ, Solorzano CC, Lee JK et al.: Thyroidectomy remains an effective treatment option for Graves disease. Am J Surg 2006; 191: 400-05.
• Lal G, Ituarte P, Kebebew E et al.: Should total thyroidectomy become the preffered procedure for surgical managment of Graves disease? Thyroid 2005; 15: 569-74.[Crossref]
• Ku CF, Lo CY, Chan WF et al.: Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves disease. ANZ J Surg 2005; 75: 528-31.[Crossref][PubMed]
• Van De Velde CJH, Hamming JF, Goslings BM et al.: Report of the consensus development conference on the management of differentiated thyroid cancer in the Netherlands. Eur J Cancer Clin Oncol 1988; 24: 287-92.
• Phillips AW, Fenwick JD, Mallick UK et al.: The impact of clinical guidelines on surgical managment in patients with thyroid cancer. Clin Oncol 2003; 15: 485-89.[Crossref]
• Beenken S, Roye D, Weiss H et al.: Extend of surgery for intermediate- risk well-differentiated thyroid cancer. Am J Surg 2000; 179: 51-6.
• Kebebew E, Duh QY, Clark OH: Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model. Word J Surg 2000; 24: 1295-1302.[Crossref]
• Solomon BL, Wartofsky L, Burman KD: Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 1996; 81: 333-39.
• Lang W, Borrusch H, Bauer L: Occult carcinomas: evaluation of 1020 sequential autopsies. Am J Clin Pathol 1988; 90: 72-76.[PubMed]
• Baudin E, Travagli JP, Ropers J: Microcarcinoma of the thyroid gland. Cancer 2000; 83: 553-59.
• Pomorski L, Pasieka Z, Kuzdak K: Mikrorak brodawkowaty tarczycy - doświadczenia własne. Pol Przegl Chir 2008;11: 1104-11.
• Winsa B, Rastad J, Larsson E: Total thyroidectomy in therapy: resistant Graves' disease. Surgery 1994; 116: 1068-74.
• Konturek A, Barczyński M, Cicoń S i wsp.: Rola całkowitej tyreoidektomii w leczeniu oftalmopatii naciekowo - obrzękowej w przebiegu choroby Graves-Basedowa. Pol Przegl Chir 2008; 9: 844-59.
• Moalem J, Suhl L, Duh QY: Treatment and prevention of reccurence of multinodular goiter: an evidence-based review of the literature. World J Surg 2008; 32: 1301-12.[WoS][Crossref]
• Hegedus L, Bonnema SJ, Bennedback FN: Managment of simple nodular goiter: current status and future perspectives. Endoc Rev 2003; 24: 102-32.[Crossref]
• Liu Q, Djuricin G, Prinz RA: Total thyroidectomy for benign thyroid disease. Surgery 1998; 123: 2-7.
• Reeve TS, Delbridge L, Brady P et al.: Secondary thyroidectomy: a twenty-year experience. World J Surg 1988; 12: 449-53.[Crossref]
• Reeve TS, Delbridge L, Cohen A et al.: Total thyroidectomy: the preffered option for multinodular goiter. Ann Surg 1987; 206: 782-85.
• Wadstrom C, Zedenius J, Guinea A: Multinodular goiter presenting as a single nodule: how effective is hemithyroidectomy. ANZ Surgery 1997; 67: A25.
• Khadra M, Delbridge L, Reeve TS et al.: Total thyroidectomy: its role in the management of thyroid disease. ANZ Surgery 1992; 62: 91-95.
• Harness JK, Fung L, Thompson NW: Total thyroidectomy: complications and technique. World J Surg 1986; 10: 781-86.[Crossref][PubMed]
• Thomusch O, Machens A, Sekula C et al.: Multivariate analysis of risk factors for postoperative complications in benign thyroid disorders in an endemic region. World J Surg 2001; 25: 307-10.
• Pattou F, Combemale F, Fabre S: Hypocalcaemia following thyroid surgery incidence and prediction of outcome. World J Surg 1998; 22: 718.[PubMed][Crossref]
• De Roy van Zuidewijn DBW, Songun I, Kievit J: The aetiology, investigation and management of surgical disorders of the thyroid gland. ANZ Surgery 1996; 66: 481.
• Rios A, Rodriguez JM, Balsalobre MD et al.: Results of surgery for toxic multinodular goiter. Surg Today 2005; 35: 901-06.[PubMed][Crossref]
• Moore FD: Oral calcium supplements to enhance early discharge after bilateral surgical treatment of the thyroid gland or exploration of the parathyroid glands. J Am Coll Surg 1994; 178: 11-16.
• Sturniolo GS, D'Avila C, Tonante A et al.: The reccurent laryngeal nerve related to thyroid surgery. Am J Surg 1999; 177: 485-88.
• Wagner HE, Seiler CA: Recurrent laryngeal nerve palsy after thyroid gland surgery. Br J Surg 1994; 81: 226-28.
• Mishra A, Agarwal G, Agarwal V et al.: Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg 2001; 25: 307-10.[Crossref]

Identifiers

DOI

10.2478/v10035-010-0002-4